Cover

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.

Study Finds Significant Variability in Doctors’ Angioplasty Mortality Rates

 

April 10, 2017—The American College of Cardiology (ACC) recently announced the publication of a study that found that some doctors have higher or lower than expected death rates from percutaneous coronary intervention (PCI) procedures; however, doctors should not be judged solely on the rate of patients who die from the procedure. The rate is highly variable over time, according to the study by Jacob A. Doll, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2017;10:672–682).

According to ACC, the study analyzed data from the National Cardiovascular Data Registry CathPCI Registry to determine how many physicians had mortality rates outside the expected norm. The study included 3,760 doctors who performed 2,343,693 PCI procedures. The investigators adjusted for a number of factors, including how sick patients were.

The investigators found a small, but significant, number of doctors (6.5%) with mortality rates above what would be expected, as well as a small, but significant, number (4.1%) with mortality rates below what would be expected.

In the ACC announcement, Dr. Doll commented that PCI mortality rates for individual doctors may be useful for both doctors and hospitals to assess and monitor their care and see where they need improvement. He stated, “It could drive hospitals and doctors to further improve the safety of a procedure that’s already low-risk. However, I don’t see this measure as ready for widespread use as a publicly reported measure or to influence payment.” Dr. Doll is a cardiologist at the University of Washington in Seattle, Washington.

As noted in the ACC announcement, a limitation with assessing mortality rates is that it is rare for patients to die from PCI—for every 100 procedures, only slightly more than 1% of patients die, and for elective PCI, death is very rare.

Dr. Doll continued, “Any given doctor may have only one or two deaths a year—some years just by chance you may have two or four, which seems like a lot, and the next year, you may have none. This may be further confounded by the low number of deaths that can be ascribed to the procedure, and makes it challenging to know whether these differences are actually due to the care received.”  He added that a number of factors affect a physician’s PCI mortality rate. Because procedures performed on sicker patients often have higher mortality rates, Dr. Doll and colleagues took this into account, by using what is called a risk standardized mortality rate. “This helps us interpret the results to determine who really has a higher-than-expected morality rate, and who has a higher actual mortality rate because they take care of sicker patients,” noted Dr. Doll.

In an editorial accompanying the study in JACC: Cardiovascular Interventions, Michael McDaniel, MD, said that doctors concerned about their mortality rate being reported publicly may avoid treating the highest-risk patients (2017;10:683–685). Dr. McDaniel is an assistant professor of medicine at Emory University School of Medicine in Atlanta, Georgia.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.